Kanzius segment on 60 minutes this Sunday

[Rich66]

http://www.cbsnews.com/stories/2009/...n5386080.shtml

[Jackie07]

Sounds interesting. Thanks.

I found the doctor's bio on the web:

Dr. Steven A. Curley received his medical degree from the University of Texas Medical School at Houston. He completed a general surgery residency at the University of New Mexico Hospitals, and then completed a fellowship in Surgical Oncology at the University of Texas M. D. Anderson Cancer Center. Dr. Curley has been on the faculty in the Department of Surgical Oncology at the University of Texas M. D. Anderson Cancer Center since completing his fellowship. He is now Professor of Surgery, Chief of Gastrointestinal Tumor Surgery, and Program Director of Multidisciplinary Gastrointestinal Cancer Care at M. D. Anderson. Dr. Curley’s clinical practice and research focuses on surgical and new treatments for patients with primary or metastatic liver tumors. Dr. Curley has been a pioneer in designing new treatments for patients with liver tumors, including radiofrequency ablation, improved techniques for surgical removal of liver cancers, and several types of direct tumor injection therapy.

Dr. Curley is principal investigator on a number of protocols at M. D. Anderson involving radiofrequency ablation of liver tumors or use of novel therapies to treat hepatocellular cancer or colorectal cancer liver metastases. He is also principal investigator on an international protocol involved in screening high-risk hepatitis virus patients for hepatocellular cancer and then using surgical therapy, radiofrequency ablation, or other direct injection treatments to treat patients diagnosed with small hepatocellular cancers. Dr. Curley is the author or co-author of over 110 publications, and 30 book chapters, many dealing with the treatment of patients with hepatocellular cancer, gallbladder cancer, bile duct cancer, or liver metastases from a number of different tumor types.


Dr. Paul Cherukuri is the lead research scientist on the Kanzius project with Dr. Curley. Dr. Cherukuri received his B.S. in physics at the University of Kentucky and his Ph.D. in physical chemistry under the supervision of Nobel Laureate, Prof. Richard E. Smalley and Prof. Bruce Weisman at Rice University. He recently joined the University of Texas MD Anderson Cancer Center as an assistant professor in the departments of Surgical Oncology and Experimental Therapeutics.

Dr. Cherukuri is concurrently a visting scholar in George Whitesides' research group at Harvard University in the Department of Chemistry and Chemical biology and is also an adjunct professor of Chemistry at Rice University. His research at MD Anderson involves the development of advanced nanoscale diagnostic and therapeutic devices, with an emphasis on the electrodynamic response of nanoscale materials.